Sherman Oaks, CANCT06125951Now EnrollingIRB Ready

Alzheimer's Disease Clinical Trial in Sherman Oaks, CA

Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Sherman Oaks. Study-provided care at no cost to qualified participants.

Sponsored by Actinogen Medical

Quick Self-Assessment

See if you qualify for this Sherman Oaks location

Preparing your pre-screening questions...

Expert Care in Sherman Oaks

Access alzheimer's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related alzheimer's disease treatment provided free

Apply for This Sherman Oaks Location

Check if you qualify for this alzheimer's disease clinical trial in Sherman Oaks, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sherman Oaks

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sherman Oaks site if eligible
  4. 4Begin participation

About This Alzheimer's Disease Study in Sherman Oaks

Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer's Disease (AD) and Major Depressive Disorder (MDD). This XanaMIA Phase 2b/3 study is to investigate the safety, tolerability, and efficacy of Xanamem in in mild or moderate dementia due to AD. Trial participants will be randomized to either receive 10mg of Xanamem once daily or a placebo for 36 weeks at a 1:1 ratio in a double-blinded fashion.

Sponsor: Actinogen Medical

Who Can Participate

Inclusion Criteria

Male or female aged 50 years or older, inclusive at the time of Screening.
Clinical syndrome of mild or moderate dementia, likely to be due to AD in the opinion of the Investigator, at Screening, including meeting the following criteria: 1. Clinical Dementia Rating (CDR) global score of 0.5 to 1.0 2. Mini-mental state examination (MMSE) score of 18 to 26 3. Magnetic resonance imaging (MRI) or computerized tomography (CT) scan within 1 year prior to randomization that excludes alternative diagnoses for dementia such as large stroke, likely vascular dementia, brain tumor, subdural hematoma, or other non-AD dementia type findings 4. Positive plasma AD biomarker signature at Pre-screening, comprising fasting levels of a tau species protein.
If receiving symptomatic AD medications, the dosing regimen must have been stable for 3 months prior to Screening.
Has a consenting trial partner who, in the Investigator's judgment, has frequent and sufficient cont

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sherman Oaks?

Yes, this clinical trial (NCT06125951) has an active research site in Sherman Oaks, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Alzheimer's Disease Treatment Options in Sherman Oaks, CA

If you're searching for alzheimer's disease treatment options in Sherman Oaks, CA, this clinical trial (NCT06125951) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sherman Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all alzheimer's disease clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Sherman Oaks, CA

See all alzheimers disease clinical trials recruiting in Sherman Oaks — not just this study.

Browse Alzheimers Disease Trials in Sherman Oaks →

Browse More Trials by Condition

Alzheimers Disease TrialsAnkylosing Spondylitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Sherman Oaks?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sherman Oaks, CA